Immunotherapy and Antivascular Targeted Therapy in Patients' Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

OBJECTIVE: To analyze the therapeutic effects and organ rejection of anti-PD-1 immunotherapy or antivascular targeting therapy on patients with combined malignancies after organ transplantation. METHODS: We collected retrospective studies on “post-transplantation, cancer, immunotherapy, and vascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Bairu, Guo, Zi, Huang, Peng, Tan, Minghua, Zhang, Xiaoshen, Lin, Siyao, Song, Changshan, Wang, Jiaqing, Huang, Minqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184147/
https://www.ncbi.nlm.nih.gov/pubmed/35692497
http://dx.doi.org/10.1155/2022/6440419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184147/
https://www.ncbi.nlm.nih.gov/pubmed/35692497
http://dx.doi.org/10.1155/2022/6440419

Ejemplares similares